Category: News

By: John A. Hovanesian, MD, FACS One of the strongest motivators for choosing a career in medicine is a sense of duty to help our fellow man. Through our early medical training, many of us gain a special desire to help those in far-reaching places where medical care is less abundant. As a relatively new… Read More

By: John A. Hovanesian, MD, FACS Believe it or not, it’s only been 15 years since the use of electronic health records became common in the U.S. Many of our early-career colleagues grew up in medicine with these systems already in place and never experienced the challenges of starting to use EHR when these systems were not really… Read More

Information on initial experience complements clinical trial data. By: Savak “Sev” Teymoorian, MD, MBA In recent years, glaucoma specialists have witnessed exciting therapeutic developments aimed at addressing important unmet clinical needs for patients. Topical agents often remain first-line therapies in the armamentarium, with demonstrated efficacy and safety results in the clinical trial setting. However, as… Read More

Laguna Hills, CA, April 12th, 2023 – An ophthalmic surgeon, John Hovanesian, M.D., from Harvard Eye Associates was named as one of the 100 most influential people worldwide in eye care by the UK publication The Ophthalmologist. This year’s “Power List” has a special focus on “10 Years of Excellence and Impact” in ophthalmology. The… Read More

Innovation is changing the philosophy of glaucoma treatment from a drop-dependent approach to an interventional, procedure-based approach, according to Savak Teymoorian, MD. “In the pursuit of making glaucoma care better, we ask ourselves, what can we do to improve our patients’ therapy? We realized that eye drop options, as they stand, simply wouldn’t be the… Read More

Harvard Eye Associates Awarded on Newsweek’s America’s Best Ophthalmologists 2021 List Laguna Hills, CA – Dr. John A. Hovanesian has been awarded on Newsweek’s list of America’s Best Ophthalmologists 2021. Newsweek and Statista Inc. announced this prestigious award list on July 21st, 2021 and it can currently be viewed on Newsweek’s website. America’s Best Ophthalmologists… Read More

The Latest DURYSTA™ Glaucoma Treatment Board-Certified Ophthalmologist, Dr. Savak Teymoorian of Harvard Eye Associates, assisted in the research and development of a new glaucoma drug. Laguna Hills, Ca.—Harvard Eye Associates is able to offer patients dealing with glaucoma a revolutionary new eye treatment that was researched and developed by one of its own board-certified ophthalmologists,… Read More